Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anastasia Vishnevetsky

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
European Stroke Journal|August 9, 2023
Migraine and the risk of cervical artery dissection: A systematic review and meta-analysisZihan Sun, Julian Kleine-Borgmann, Joome Suh, et al.
JAMA Otolaryngology-- Head & Neck Surgery|September 26, 2024
Cutaneous Squamous Cell Carcinoma in Transketolase DeficiencyNicole Loranger, Anastasia Vishnevetsky, Michele Spencer-Manzon, et al.
Eneurologicalsci|May 24, 2017
The First Report of CADASIL in Peru: Olfactory Dysfunction on Initial PresentationAnastasia Vishnevetsky, Miguel Inca-Martinez, Karina Milla-Neyra, et al.
Neurology|July 8, 2018
Neurology outreach clinic for Huntington disease in Peru: Lessons for neurodegenerative diseasesAnastasia Vishnevetsky, Maryenela Illanes-Manrique, Miguel Inca-Martinez, et al.
Revista Peruana De Medicina Experimental Y Salud Publica|January 7, 2016
[Neurogenetics in Peru, example of translational research]Pilar Mazzetti, Miguel Inca-Martínez, Indira Tirado-Hurtado, et al.
Annals of Clinical and Translational Neurology|February 28, 2023
Low mortality rate in a large cohort of myelin oligodendrocyte glycoprotein antibody disease (MOGAD)Itay Lotan, Gabriela Romanow, Rebecca Salky, et al.
Movement Disorders Clinical Practice|February 24, 2023
Juvenile-Onset Huntington's Disease in Peru: A Case Series of 32 PatientsAnastasia Vishnevetsky, Mario Cornejo-Olivas, Elison Sarapura-Castro, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 5, 2024
Effectiveness of immunotherapies in relapsing myelin oligodendrocyte glycoprotein antibody-associated diseasePhilippe Antoine Bilodeau, Anastasia Vishnevetsky, Negar Molazadeh, et al.
Multiple Sclerosis and Related Disorders|March 17, 2023
Multiple types of relapses in MOG antibody diseaseMichael Levy, Negar Molazadeh, Philippe Antoine Bilodeau, et al.
Multiple Sclerosis and Related Disorders|December 20, 2025
Neuropsychologic impact of MOGAD: A patient reported outcomes studyBruna Leles, Yihan Zhang, Philippe A Bilodeau, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
European Stroke Journal|August 9, 2023
Migraine and the risk of cervical artery dissection: A systematic review and meta-analysisZihan Sun, Julian Kleine-Borgmann, Joome Suh, et al.
JAMA Otolaryngology-- Head & Neck Surgery|September 26, 2024
Cutaneous Squamous Cell Carcinoma in Transketolase DeficiencyNicole Loranger, Anastasia Vishnevetsky, Michele Spencer-Manzon, et al.
Eneurologicalsci|May 24, 2017
The First Report of CADASIL in Peru: Olfactory Dysfunction on Initial PresentationAnastasia Vishnevetsky, Miguel Inca-Martinez, Karina Milla-Neyra, et al.
Neurology|July 8, 2018
Neurology outreach clinic for Huntington disease in Peru: Lessons for neurodegenerative diseasesAnastasia Vishnevetsky, Maryenela Illanes-Manrique, Miguel Inca-Martinez, et al.
Revista Peruana De Medicina Experimental Y Salud Publica|January 7, 2016
[Neurogenetics in Peru, example of translational research]Pilar Mazzetti, Miguel Inca-Martínez, Indira Tirado-Hurtado, et al.
Annals of Clinical and Translational Neurology|February 28, 2023
Low mortality rate in a large cohort of myelin oligodendrocyte glycoprotein antibody disease (MOGAD)Itay Lotan, Gabriela Romanow, Rebecca Salky, et al.
Movement Disorders Clinical Practice|February 24, 2023
Juvenile-Onset Huntington's Disease in Peru: A Case Series of 32 PatientsAnastasia Vishnevetsky, Mario Cornejo-Olivas, Elison Sarapura-Castro, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 5, 2024
Effectiveness of immunotherapies in relapsing myelin oligodendrocyte glycoprotein antibody-associated diseasePhilippe Antoine Bilodeau, Anastasia Vishnevetsky, Negar Molazadeh, et al.
Multiple Sclerosis and Related Disorders|March 17, 2023
Multiple types of relapses in MOG antibody diseaseMichael Levy, Negar Molazadeh, Philippe Antoine Bilodeau, et al.
Multiple Sclerosis and Related Disorders|December 20, 2025
Neuropsychologic impact of MOGAD: A patient reported outcomes studyBruna Leles, Yihan Zhang, Philippe A Bilodeau, et al.
Pageof 3